A Dark Vector Cognition product

Item 5. OTHER INFORMATION

1K characters. Original on sec.gov ·

Item 5. OTHER INFORMATION

During the three months ended September 30, 2026, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted, modified, or terminated a “Rule 10b5-1 trading agreement” or “non-Rule 10b5-1 trading agreement,” as each term is defined in Item 408 of Regulation S-K of the Exchange Act, except as follows:

On September 15, 2026, Sherri Luther, the Company’s Chief Financial Officer, entered into a 10b5-1 trading arrangement (the “10b5-1 Plan”) for the sale of 8,956 shares of the Company’s common stock, and the potential sale of a portion of the net shares of the Company’s common stock resulting from the vesting of various performance share and restricted share award vesting during 2027. The 10b5-1 Plan, scheduled to commence on January 14, 2027, is intended to satisfy the affirmative defense of Rule 10b5-1(c) and will terminate on December 31, 2027.

Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS